Literature DB >> 29941477

Hermansky-Pudlak syndrome with a novel genetic variant in HPS1 and subsequent accelerated pulmonary fibrosis: significance for phenocopy diseases.

Oliver J McElvaney1, Marjan Huizing2, William A Gahl2, Paul O'Donovan3, Deirdre Horan1, P Mark Logan4, Emer P Reeves1, Noel G McElvaney1.   

Abstract

The Hermansky-Pudlak syndrome (HPS) is a collection of autosomal-recessive disorders characterised by tyrosinase-positive oculocutaneous albinism (OCA), bleeding diatheses and, in selected individuals, early-onset accelerated pulmonary fibrosis, neutropaenia and granulomatous colitis. We describe a young man who presented following a self-directed literature review prompted by severe bleeding complications following minor surgical and dental procedures in the context of OCA. HPS was clinically suspected, with subsequent genetic testing confirming biallelic mutations in the HPS1 gene. Of interest, this is the only described HPS type 1 patient with two different (compound heterozygote) splice site variants in HPS1 In addition to detailing a novel genetic result and outlining the progressive clinical course of disease in this case, we discuss the management of HPS, the prognostic value of subtype analysis and the technical difficulties relating to transplantation in the case of HPS-associated advanced pulmonary fibrosis. This case also illustrates the concept of lung phenocopy relationships and the potential for elucidating the pathogenesis of more common pulmonary disorders by studying genetic diseases that result in similar phenotypes. Furthermore, it re-emphasises the importance of the patient voice, particularly with regard to complex diagnoses and rare diseases. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  alpha1 antitrypsin deficiency; bronchiectasis; cystic fibrosis; interstitial fibrosis; lung transplantation; rare lung diseases

Mesh:

Substances:

Year:  2018        PMID: 29941477     DOI: 10.1136/thoraxjnl-2018-211920

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.

Authors:  Martina Doubková; Jakub Trizuljak; Zuzana Vrzalová; Anna Hrazdirová; Ivona Blaháková; Lenka Radová; Šárka Pospíšilová; Michael Doubek
Journal:  BMC Pulm Med       Date:  2019-10-16       Impact factor: 3.317

2.  Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience.

Authors:  Luke Benvenuto; Seema Qayum; Hanyoung Kim; Hilary Robbins; Lori Shah; Angela Dimango; Gabriela Magda; Harpreet Grewal; Philippe Lemaitre; Bryan P Stanifer; Joshua Sonett; Frank D'Ovidio; Selim M Arcasoy
Journal:  Transplant Direct       Date:  2022-03-23

3.  Clinical Features and Novel Genetic Variants Associated with Hermansky-Pudlak Syndrome.

Authors:  Chonglin Chen; Ruixin Wang; Yongguang Yuan; Jun Li; Xinping Yu
Journal:  Genes (Basel)       Date:  2022-07-20       Impact factor: 4.141

4.  Hermansky-Pudlak syndrome: Mutation update.

Authors:  Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico
Journal:  Hum Mutat       Date:  2020-01-23       Impact factor: 4.700

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.